Zimmer Biomet Holdings, Inc. (ZBH)
85.14
+1.44
(+1.72%)
USD |
NYSE |
May 18, 16:00
85.13
-0.01
(-0.01%)
After-Hours: 20:00
Zimmer Biomet Holdings Research and Development Expense (Quarterly) : 103.40M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp. | 404.00M |
| Intuitive Surgical, Inc. | 361.60M |
| Artivion, Inc. | 8.841M |
| Edwards Lifesciences Corp. | 263.30M |
| PetVivo Holdings, Inc. | 0.323M |